Cargando…

Proteomics research of SARS-CoV-2 and COVID-19 disease

Currently, coronavirus disease 2019 (COVID-19) is still spreading in a global scale, exerting a massive health and socioeconomic crisis. Deep insights into the molecular functions of the viral proteins and the pathogenesis of this infectious disease are urgently needed. In this review, we comprehens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Nan, Wang, Siyuan, Wong, Catherine C.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2022
Materias:	Special Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388787/ https://www.ncbi.nlm.nih.gov/pubmed/37724330 http://dx.doi.org/10.1515/mr-2022-0016

Ejemplares similares

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Preventive measures for health workers exposed to COVID-19 (SARS-CoV-2)
por: Astete-Cornejo, Jonh, et al.
Publicado: (2022)

The potential association between PARP14 and the SARS-CoV-2 infection (COVID-19)
por: Tauber, Amanda L, et al.
Publicado: (2021)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Cardiovascular disease in SARS‐CoV‐2 infection
por: Sato, Kei, et al.
Publicado: (2021)

A matter of perspective—Cutting-edge technology-driven urine proteome in COVID-19
por: Wang, Siyuan, et al.
Publicado: (2021)

SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical–pathologic correlations
por: Schwartz, David A., et al.
Publicado: (2023)

SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling
por: Lai, Dan-yun, et al.
Publicado: (2022)

Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
por: Davoodi, Poorya, et al.
Publicado: (2021)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

COVID-19 in Children and Safety of SARS-CoV-2 Immunization in Children: Statement of the International Pediatric Association
por: Thacker, Naveen, et al.
Publicado: (2021)

Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology()
por: Saldarriaga Rivera, Lina María, et al.
Publicado: (2020)

Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)
por: Won, Joungha, et al.
Publicado: (2020)

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
por: Bhardwaj, Taniya, et al.
Publicado: (2023)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges
por: Cooper, Dan M., et al.
Publicado: (2021)

Imaging Findings of SARS-CoV-2 Infection in Pediatrics: A Systematic Review of Coronavirus Disease 2019 (COVID-19) in 850 Patients
por: Katal, Sanaz, et al.
Publicado: (2020)

Recommendations on cardiopulmonary resuscitation in patients with suspected or confirmed SARS-CoV-2 infection (COVID-19). Executive summary()()
por: Rodríguez Yago, M.A., et al.
Publicado: (2020)

Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2
por: Avula, Nandini, et al.
Publicado: (2023)

A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases
por: Soni, Niraja, et al.
Publicado: (2020)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
por: Zhao, Lele, et al.
Publicado: (2022)

SARS-CoV-2 and Chlamydia pneumoniae co-infection: A review of the literature
por: Frutos, María Celia, et al.
Publicado: (2022)

Research Response to SARS-CoV-2/COVID-19
por: Burger, Charles D., et al.
Publicado: (2020)

Reply to: SARS‐CoV‐2 as a Potential Trigger of Neurodegenerative Diseases
por: Outeiro, Tiago F., et al.
Publicado: (2020)

The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period
por: Khosroshahi, Hamid Tayebi, et al.
Publicado: (2021)

The zinc proteome of SARS-CoV-2
por: Andreini, Claudia, et al.
Publicado: (2022)

Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma
por: Pazgan-Simon, Monika, et al.
Publicado: (2022)

Inflammation, malnutrition, and SARS-CoV-2 infection: A disastrous combination()
por: Carretero Gómez, J., et al.
Publicado: (2020)

Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection
por: Tan, Jie, et al.
Publicado: (2020)

Preliminary pragmatic lessons from the SARS-CoV-2 pandemic in France
por: Gauss, Tobias, et al.
Publicado: (2020)

Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2
por: Li, Yue, et al.
Publicado: (2020)

Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources
por: Abdalhamid, Baha, et al.
Publicado: (2020)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t573vcl5nhcctidglpn51nl17r